Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Breast Carcinoma In Situ × Anastrozole × Clear all

Phase

Phase 2 3 Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 11 Triple Negative Breast Neoplasms 1 Osteoporosis 1 Neoplasm Metastasis 1 Joint Diseases 1 Breast Carcinoma In Situ 1 Bone Diseases, Metabolic 1

Interventions

exemestane 1 Toremifene 1 Tamoxifen 1 Letrozole 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03238703 2018-12-27

Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer

Fred Hutchinson Cancer Center

Phase 4 Withdrawn

Breast Carcinoma In Situ, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡